2009-2013 YILLARI ARASINDA TAKSİM-GAZİOSMANPAŞA EĞİTİM VE ARAŞTIRMA HASTANESİNDE OPERE EDİLEN JİNEKOLOJİK MALİGNİTE VAKALARININ RETROSPEKTİF DEĞERLENDİRİLMESİ

Amaç: İstanbul’da bir eğitim ve araştırma hastanesinde opere edilen jinekolojik kanser vakalarının sosyodemografik karakteristiklerinin ve sıklıklarının değerlendirilmesi. Gereç-Yöntem: Retrospektif düzenlenen bu çalışmada 2009-2013 yılları arasında opere edilen jinekolojik kanser vakaları değerlendirildi. Hastane kayıt bilgileri eksiksiz olan 84 vaka çalışmaya dahil edildi. Vakaların sosyo-demografik özellikleri, tanıları, yapılan ameliyat, ameliyat sonrası patoloji raporları, evre özellikleri çalışma veri kaynakları olarak kullanıldı. Bulgular: Vakaların %46’sı over, %30’u uterin korpus, %13,1’i serviks, %2,4’ü vulva ve %1,2’si vajen kanseridir. %1,2 vakada primer peritoneal karsinom mevcuttur. Evre III-IV hastalık over kanserlerinde %42, endometriyum kanserlerinde %20, serviks kanserinde %9’dur.Tüm vakaların yaş ortalaması 55,63 ± 13,72’dir. Ortalama term doğum sayısı 2,35 ± 2,08, vücut kitle indeks ortalması 28,72 ± 2,55’tir. Vakaların yarıdan fazlasında başvuru şikayeti pelvik ağrı ve postmenapozal kanamadır. Diğer başvuru şikayetleri düzensiz menstruasyon, abdominal şişkinlik ve vajinal akıntıdır. Sonuç: Bölgemizde over kanseri diğer jinekolojik kanserlerden daha sıktır. Ek olarak ileri evre hastalık, over kanserlerinde daha sık olarak görülmektedir. Non-spesifik belirti olan pelvik ağrı jinekolojik kanserlerde sık rastlanan bir semptomdur. Kadınların bu belirtiyi ihmal etmemelerinin sağlanması önemlidir. Anahtar Sözcükler: Kadın genital tümörleri, ednometriyal neoplaziler, ovaryen neoplaziler, uterin servikal neoplaziler

Retrospective Evaluation Of Operated Gynecological Malignancies Between 2009-2013 in Gaziosmanpaşa - Taksim Training And Research Hospital

Aim: Evaluation of gynecological oncology cases performed in an educational research hospital in terms of sociodemographic characteristics Methods: In this retrospective study, the gynecological oncology cases performed between 2009 and 2013 were evaluated. 84 cases with complete hospital record information were included into the study. The sociodemographic characteristics of the cases, the diagnoses, the operation performed, post-operative pathology reports, stage characteristics were used as data sources. Results: 46% of the cases were over, 30% were uterine corpus, 13,1% were cervix, 2,4% were vulva and 1,2% were vaginal cancer. Primary peritoneal carcinoma was detected in 1,2% of cases. Stage III-IV disease is 42% in over-cancer, 20% in endometrial cancer, and 9% in cervical cancer.The average age of all cases was 55,63 ± 13,72. The mean number of term births was 2,35 ± 2,08, the mean body mass index was 28,72 ± 2,55. More than half of the complaints of our gynecological cancer cases were pelvic pain and postmenopausal bleeding. Other complaints were irregular menstruation, abdominal swelling, vaginal discharge. Conclusion: Over cancer in our region is more common than other gynecological cancers. In addition, advanced disease is more common in over cancer. Pelvic pain, a non-specific symptom, is a common symptom in gynecologic cancers. It should be ensured that women do not neglect this symptom. Keywords: Female genital neoplasms, endometrial neoplasms, ovarian neoplasms, uterin cervical neoplasms

PDF

___

1. Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study. JAMAOncology June 2,2018. doi:10.1001/ jamaoncol. 2018.2706.
2. Gultekin M, Dundar S, Kucukyildiz I, Karaca MZ, Boztas G, Turan SH, et al. Survival of gynecological cancers in Turkey: where are we at?J Gynecol Oncol. 2017;28(6):e85.
3. Pınar I, Algıer L, Doğan N, Kaya N. Determination of the Risk Factors in Individuals with Gynecological Cancer. Int J Hematol Oncol Stem Cell Res. 2008;(4):208-16.
4. Lyngea E, Lönnbergb S, Törnberg S. Cervical cancer incidence in elderly women-biology or screening history?Eur J Cancer. 2017;(74):82-8.
5. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus–associated cancersUnited States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661-6.
6. Purdie DM, and GreenAC.Best Pract Res Clin Obstet Gynaecol;15(3):341-54.
7. Kheiri SA, Kunna A, Babiker AY, Alsuhaibani SA, Ahmed RY, Alsammani MA. Histopathological Pattern and Age Distribution of Malignant Ovarian Tumor among Sudanese Ladies. Maced J Med Sci. 2018;12;6(2):237-41.
8. Adegoke O,. KulasingamS, and VirnigB. Cervical cancer trends in the United States: a 35‐year population‐based analysis. J. Womens Health. 2012;(21):1031–7.
9. Eifel PJ, BurkeTW, MorrisM, and SmithTL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol1995;(59):38–44.
10. Bray FB, Carstensen H, Møller H, ZappaM, ZakeljMP, LawrenceG, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 2005;(14):2191-9.
11. Smith HO, TiffanyMF, QuallsCR, and KeyCR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24‐year population‐based study. Gynecol. Oncol. 2000;(78):97–105.
12. Visioli CB, ZappaM, CiattoS, IossaA, and CrocettiE. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985‐2000. Cancer Detect. Prev 2004;(28):461-4.
13. Oh CM, JungKW, WonYJ, ShinA, KongHJ, JunJK, et al. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009. PLoS ONE. 2013;8(8): e72012.
14. Granstrom C, Sundquist J, Hemminki K. Population attributable fractions for ovarian cancer in Swedish women by morphological type. Br J Cancer. 2008;(98):199-205.
15. DeVita VT, Lawrence TS, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 8th edition. Philadephia, USA: Lippincott Williams & Wilkins; 2008.p.214-38
16. McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol 2008;(61):152-63.
17. Purdie DM, Webb PM, Siskind V, Bain CJ, Green AC.The different etiologies of mucinous and nonmucinous epithelial ovarian cancers.Gynecol Oncol. 2003 88(1 Pt 2):S145-8.
18. Jensen KE, SchmiedelS, Norrild B,Frederiksen K,Iftner T,and KjaerSK. Risk for Cervical Intraepithelial Neoplasia Grade 3 or Worse in Relation to Smoking among Women with Persistent Human Papillomavirus Infection. Cancer Epidemiol Biomarkers Prev. 2012;21(11):1949-55.
19. WuQJ, Li YY, Tu C, Zhu J, Qian KQ, Feng TB, et al. Parity and endometrial cancer risk: a meta-analysis of epidemiological studies. Sci Rep. 2015;(5): 14243.
20. Schonfield SJ, Hartge P, Pfeiffer RM,Freedman DM, Greenlee RT, Linet MS, et al. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer. 2013;1;119(7):1393-401.
21. Fortner RT, Ose J, Merritt MA, Schock H, Tjønneland A, Hansen L,et al. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort. Int J Cancer. 2015;137(5): 1196-208.
22. Yang HP, Trabert B, Murphy MA, Sherman ME, Sampson JN, Brinton LA, et al.: Ovarian cancer risk factors by histologic subtypes in the NIH-AARP Diet and Health Study. Int J Cancer. 2012;131(4): 938-48.
23. International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S,Goodill Aet al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118(6):1481-95.
24. Jensen KE, Schmiedel S, Frederiksen K, Norrild B, Iftner T, Kjær SK. Risk for cervical intraepithelial neoplasia grade 3 or worse in relation to smoking among women with persistent human papillomavirus infection.Cancer Epidemiol Biomarkers Prev. 2016;25(7):1059-63.
25. Zeng XT, Xiong PA, Wang F, Li CY, Yao J, Guo Y. Passive smoking and cervical cancer risk: a meta-analysis based on 3,230 cases and 2,982 controls. Asian Pac J Cancer Prev. 2012;13(6):2687-93.
26. Ashley S. Felix, Hannah P. Yang, Gretchen L. Gierach, et al. Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity. Cancer Causes Control. 2014;25(4): 479-89.
27. Mette T. Faber, Kjær SK, Dehlendorff C, Claude JC, Andersen KK, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case–control studies. Cancer Causes Control. 2013;24(5).
28. Poorolajal J, Jenabi E.The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232-8.
29. Onstad MA, Schmandt RE, Lu KH. Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment. J Clin Oncol. 2016;10;34(35): 4225-30.
30. Braem MG, Onland-Moret NC, van den Brandt PA, Goldbohm RA, Peeters PH, Kruitwagen RF,et al. Reproductive and hormonal factors in association with ovarian cancer in the Netherlands cohort study. Am J Epidemiol. 2010;172(10):1181-9.
31. Schouten LJ, Goldbohm RA, van den Brandt PA: Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol. 2003;157(5): 424-33.
32. Engeland A, Tretli S, Bjørge T: Height, body mass index, and ovarian cancer: a follow-up of 1.1 million Norwegian women. J Natl Cancer Inst. 2003;95(16): 1244-8.
33. Aune D, Navarro Rosenblatt DA, Chan DS, Abar L,Vingeliene S, Vieira AR,et al. Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Int J Cancer. 2015;136(8):1888-98.
34. Lahmann PH, Cust AE, Friedenreich CM, Schulz M, Lukanova A, Kaaks R, et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010;126(10):2404-15.
35. Lyratzopoulos G, Abel G, Brown C, Rous BA, Vernon SA, Roland M, et al. Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Annals of Oncology. 2013;24(3):843-50.
36. Funston G, O’Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ. Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals. Adv Ther. 2018;35(4):577-89.